Cambridge Investment Research Advisors, Inc. Abbott Laboratories Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 315,203 shares of ABT stock, worth $35.4 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

315,203

Previous 292,354 7.82%

Holding current value

$35.4 Million

Previous $30.4 Million 18.29%

% of portfolio

0.12%

Previous 0.11%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$100.07 - $118.13 $2.29 Million - $2.7 Million	22,849 Added 7.82%	315,203 $35.9 Million
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $693,828 - $774,486	-6,888 Reduced 2.3%	292,354 $30.4 Million
Q1 2024 Apr 24, 2024	BUY	$109.52 - $120.96 $2.59 Million - $2.86 Million	23,614 Added 8.57%	299,242 $34 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $1.34 Million - $1.64 Million	14,860 Added 5.7%	275,628 $30.3 Million
Q3 2023 Oct 24, 2023	SELL	$95.53 - $114.62 $2.08 Million - $2.49 Million	-21,737 Reduced 7.69%	260,768 $25.3 Million
Q2 2023 Jul 13, 2023	BUY	$100.78 - $112.29 $2.64 Million - $2.94 Million	26,202 Added 10.22%	282,505 $30.8 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $1.44 Million - $1.69 Million	-14,848 Reduced 5.48%	256,303 $26 Million
Q4 2022 Feb 08, 2023	BUY	$95.06 - $111.52 $524,921 - $615,813	5,522 Added 2.08%	271,151 $29.8 Million
Q3 2022 Oct 17, 2022	BUY	$96.76 - $112.03 $40,058 - $46,380	414 Added 0.16%	265,629 $25.7 Million
Q2 2022 Jul 13, 2022	BUY	$102.07 - $123.37 $119,013 - $143,849	1,166 Added 0.44%	265,215 $28.8 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $1.16 Million - $1.41 Million	-10,161 Reduced 3.71%	264,049 $31.3 Million
Q4 2021 Feb 03, 2022	BUY	$115.53 - $141.46 $502,093 - $614,785	4,346 Added 1.61%	274,210 $38.6 Million
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $416,592 - $460,873	3,571 Added 1.34%	269,864 $31.9 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $75,216 - $88,540	711 Added 0.27%	266,293 $30.9 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $58,991 - $69,500	-542 Reduced 0.2%	265,582 $31.8 Million
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $150,255 - $163,735	1,431 Added 0.54%	266,124 $29.1 Million
Q3 2020 Oct 29, 2020	BUY	$91.64 - $111.29 $1.43 Million - $1.73 Million	15,576 Added 6.25%	264,693 $28.8 Million
Q2 2020 Jul 27, 2020	BUY	$76.57 - $98.0 $555,821 - $711,382	7,259 Added 3.0%	249,117 $22.8 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $643,528 - $941,013	10,244 Added 4.42%	241,858 $19.1 Million
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $1.66 Million - $1.85 Million	21,141 Added 10.04%	231,614 $20.1 Million
Q3 2019 Nov 06, 2019	BUY	$81.84 - $88.74 $269,417 - $292,132	3,292 Added 1.59%	210,473 $17.6 Million
Q3 2019 Oct 28, 2019	SELL	$81.84 - $88.74 $3,109 - $3,372	-38 Reduced 0.02%	207,181 $17.3 Million
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $608,402 - $709,580	-8,348 Reduced 3.87%	207,219 $0
Q1 2019 May 08, 2019	BUY	$66.22 - $80.06 $654,915 - $791,793	9,890 Added 4.81%	215,567 $0
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $301,641 - $341,716	-4,601 Reduced 2.19%	205,677 $14.9 Million
Q3 2018 Nov 02, 2018	BUY	$60.81 - $73.36 $305,752 - $368,854	5,028 Added 2.45%	210,278 $0
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $178,179 - $196,656	3,095 Added 1.53%	205,250 $0
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $187,210 - $211,663	3,327 Added 1.67%	202,155 $0
Q4 2017 Feb 22, 2018	BUY	$53.68 - $57.47 $983,041 - $1.05 Million	18,313 Added 10.14%	198,828 $0
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $162,827 - $181,732	3,388 Added 1.91%	180,515 $9.63 Million
Q2 2017 Aug 08, 2017	BUY	N/A	177,127	177,127 $8.61 Million

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Abbott Laboratories Transaction History